Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Q2 Medicine
European Endocrinology Pub Date : 2020-04-01 Epub Date: 2020-02-04 DOI:10.17925/EE.2020.16.1.21
Yatan Pal Singh Balhara, Shalini Singh, Sanjay Kalra
{"title":"Pragmatic Opioid Use in Painful Diabetic Neuropathy.","authors":"Yatan Pal Singh Balhara,&nbsp;Shalini Singh,&nbsp;Sanjay Kalra","doi":"10.17925/EE.2020.16.1.21","DOIUrl":null,"url":null,"abstract":"<p><p>The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder. Risk mitigation strategies at the level of the clinician include periodic assessment and documentation of clinical details, treatment history and psychosocial status. Using a multimodal approach to pain management, medication counselling, adherence monitoring programmes, evidence-based opioid dosing strategies and empowering patients to make treatment decisions are effective strategies in reducing risk associated with prolonged opioid use. At the organisational and policy level, using prescription drug monitoring programmes, carrying out periodic opioid utilisation reviews and providing training to patients and physicians on safe opioid use are useful, implementable strategies.</p>","PeriodicalId":38860,"journal":{"name":"European Endocrinology","volume":"16 1","pages":"21-24"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308105/pdf/euendo-16-21.pdf","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/EE.2020.16.1.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/2/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 8

Abstract

The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder. Risk mitigation strategies at the level of the clinician include periodic assessment and documentation of clinical details, treatment history and psychosocial status. Using a multimodal approach to pain management, medication counselling, adherence monitoring programmes, evidence-based opioid dosing strategies and empowering patients to make treatment decisions are effective strategies in reducing risk associated with prolonged opioid use. At the organisational and policy level, using prescription drug monitoring programmes, carrying out periodic opioid utilisation reviews and providing training to patients and physicians on safe opioid use are useful, implementable strategies.

阿片类药物在疼痛性糖尿病神经病变中的实用应用。
疼痛性糖尿病神经病变的治疗是一项艰巨的临床挑战。尽管阿片类镇痛药被认为是治疗中重度神经性疼痛的二线或三线药物,但这一适应症的阿片类药物处方高于预期。这篇叙述性综述是关于如何确保阿片类药物对疼痛性糖尿病神经病变患者的实用使用,同时避免阿片类药物过量、阿片类药物转移和阿片类药物使用障碍等并发症的建议。临床医生一级的风险缓解战略包括定期评估和记录临床细节、治疗史和心理社会状况。采用多模式方法进行疼痛管理、药物咨询、依从性监测规划、基于证据的阿片类药物给药策略和赋予患者做出治疗决策的权力,是减少与长期使用阿片类药物相关风险的有效策略。在组织和政策层面,使用处方药监测规划、定期开展阿片类药物使用审查以及向患者和医生提供阿片类药物安全使用培训是有用的、可实施的战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Endocrinology
European Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信